Abstract
Despite the major contribution it provides to practical neurooncolgy, morphological imaging by CT-scanner or magnetic resonance imaging techniques (MRI) is not always able to give definite answers about the histology of the tumor, its prognosis, or to predict early the response to therapy. Stereotactic biopsy usually provides a histopathological diagnosis and sometimes allows a grading of anaplasia; but most often this information is relevant only for a limited area within the tumor. In addition, biopsies cannot be performed repeatedly during the clinical follow-up of the patient and they do not always afford an individual assessment of the evolution of the tumor nor of the presumed sensitivity to any eventual therapeutic intervention. On the other hand, it is obvious that parameters which are closely related to tumor growth are not readily identified by radiological or histological investigations since most are biochemical, pharmacological or genetic in nature. Positron emission tomography (PET) affords a simultaneous in vivo measurement of some of these parameters, both within the tumor and in the surrounding, presumably healthy, brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abe Y, Matsuzawa T, Fujiwara T, Fukuda H, Itoh M, Yamada K, Yamaguchi K, Sata T, Ito T (1986) Assessment of radiotherapeutic effects on experimental tumors using 18F-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 12: 325–328
Alavi JB, Alavi A, Goldberg HI, Dann R, Hickey W, Reivich M (1987) Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma. Nucl Med Commun 8: 457–468
Alavi JB, Alvi A, Chawluc J, Kushner M, Powe J, Hickey W, Reivich M (1988) Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074–1078
Albert KF, Forsting M, Sartor K, Adams HP, Wilson CB, Kunze S, Saloman M (1994) Early post-operative magnetic resonance imaging after resection of malignant glioma—objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45–91
Ashdown BC, Boyko OB, Uglietta JP, Friedman HS, Hockenberger B, Oakes WJ, Fuller GN (1993) Postradiation cerebellar necrosis mimicking tumor: MR appearance. J Comput Assist Tomogr 17: 124–126
Beaney RP (1984) Positron emission tomography in the study of human tumors. Semin Nucl Med 14(4): 324–341
Beaney RP, Brooks DJ, Leenders KL, Thomas DGT, Jones T, Holnan KE (1985) Blood flow and oxygen utilisation in the contralateral cortex of patients with untreated intracranial tumour as studied by positron emission tomography, with observation on the effect of decompressive surgery. J Neurol Neurosurg Psychiatry 48: 310–319
Bergstrom M, Collins VP, Ehrin E, Ericson K, Ericson L, Greitz T, Halldin C, Von Hoist H, Langstrom B, Lija A, Lundovist H, Nagren K (1983) Discreapancies in brain tumor extent as shown by computed tomography and positron emission tomography using (68GA) EDTA, (11C) glucose, and (11C) methionine, J Comp Assist Tomogr 7: 1062–1066
Bergstrom M, Ericson K, Hagenfeld L, Mosskin M, Von Hoist H, Noren G, Eriksson L, Ehrin E, Johnstrom P (1987a) PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr 11: 208–213
Bergstrom M, Lundqvist H, Ericson K, Lilja A, Johnstrom P, Langstrom B, Von-Host H, Eriksson L, Blomqvist G (1987b) Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 28: 225–229
Bergstrom M, Muhr C, Ericson K, Lundqvist H, Lilja A, Eriksson L, Blomqvist G, Langstrom B, Johnstrom P (1987c) The normal pituitary examined with PET and methyl-11 C-L-methionine and methyl-11C-D-methionine. Neuroradiology 29: 221–225
Bergstrom M, Muhr C, Lundberg PO, Gee AD, Fasth KJ, Langstrom B (1987d) Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: A PET study. J Comput Assist Tomogr 11: 815–819
Bergstrom M, Muhr C, Lundberg PO, Bergstrom K, Lungsvist H, Antoni G, Fasth KJ, Langstrom B (1987e) Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-11C-methionine and L-11C-methionine. J Comput Assist Tomogr 11: 384–389
Berlinguet L, Begin N, Babineau LM (1962) Autoradiographic studies of the distribution of 1-aminocyclopentane-carboxylic acid in normal and cancerous mice. Can J Biochem Physiol 40: 1111–1114
Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF (1995) Technicium-99m-sestamibi imaging with nitrate infusion to detect vialbe hibernating myocardium and predict postrevascularization recovery. J Nucl Med 36: 1994–2000
Black KL, Ikezaki K, Toga AW (1989) Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J Neurosurg 71: 113–118
Blasberg RG (1994) Prediction of brain tumor therapy response by PET. J Neurooncol 22: 281–286
Bolster JM Vaarlburg W, Elsinga PH, Ishiwata K, Vissering H, Voldring MG (1986) The preparation of 11C-carboxylic labelled L-methionine for measuring protein synthesis rates. J Label Comput Radiopharmaceut 23: 1081–1082
Born R, Eicholtz-Wirth H (1981) Effect of different physiological conditions on the action of Adriamycin on Chinese hamster cells in vitro. Brit J Cancer 44: 241–246
Brooks RA (1982) Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 23: 538–530
Brooks DJ, Beaney RP, Lammertsma AA, Leenders KL, Horlock PL, Kensett MJ, Marshall J, Thomas DG, Jones T (1984) Quantitative measurement of blood-brain barrier permeability using Rubidium-82 and positron emission tomography. J Cerb Blood Flow Metab 4: 535–545
Brooks DJ, Beaney RP, Lammerstma AA, Herold S, Turton DR, Luthra SK, Frackowiak RSJ, Thomas DG, Marshall J, Jones T (1986a) Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumors studied using (11C)3-0-methyl-D-glucose and positron emission tomography. J Cereb Blood Flow Metab 6: 230–239
Brooks DJ, Beaney RP, Lammertsma AA, Turton DR, Marshall J, Thomas DG, Jones T (1986b) Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography. Microvasc Res 31: 267–276
Brooks DJ, Beaney RP, Thomas DGT, Marshall J, Jones T (1986c) Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography. J Cereb Blood Flow Metab 6: 529–535
Brooks RA, Hatazawa J, Di Chiro G, Larson SM, Fishbein DS (1987) Human cerebral glucose metabolism determined by positron emission tomography: a revisit. J Cereb Blood Flow Metab 7: 427–432
Busch H, Davis JR, Honig GR, Anderson DC, Nair PV, Nyhan WL (1959) The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues. Cancer Res 19: 1030–1039
Bustamante E, Morris HP, Pedersen PL (1978) Hexokinase: the direct link between mitochondrial and glycolytic reactions in rapidly growing cancer cells. Adv Exp Med Bill 92: 363–380
Bustany P, Chatel M, Derlon JM, Darcel F, Sgouropoulos P, Soussaline F, Syrota A (1986) Brain tumor protein synthesis and histological grades: A study by positron emission tomography (PET) with C 11-L-methionine. J Neurooncol 3: 397–404
Ceccarini C, Eagle H (1971) pH as a determinant of cellular growth and contact inhibition. Proc Natl Acad Sci USA 68: 229–233
Chandrasoma P, Smith M, Apusso M (1989) Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 24: 160–165
Chi-Kwan Y, Budinger TF (1981) Evaluation of blood brain barrier permeability changes in rhesus monkeys and man using Rb-82 and positron emission tomography. J Comput Assist Tomogr 5: 792–799
Chi-Kwan Y, Yano Y, Budinger TF, Friedland RP, Derenzo SE, Huesman RH, O’Brien HA (1982) Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med 23: 532–537
Christman D, Crawford EJ, Friedkin M, Wolf APP (1972) Detection of DNA synthesis in intact organisms with positron-emitting methyl-(11C) thymidine. Proc Natl Acad Sci USA 69: 988–992
Coenen HH, Kling P, Stocklin G (1989) Cerebral metabolism of L-(2-18F) Fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med 30: 1367–1372
Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Clifford-Schold S (1991) Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32: 616–622
Comar D, Cartron JC, Mazière M, Marazano (1976) Labelling and metabolism of methionine-methyl-C 11. Eur J Nucl Med 1: 11–14
Conway T, Diksic M (1988) Synthesis of “no-carrier-added” carbon-11 SarCNU: The sarcosinamide analog of the chemotherapeutic agent BCNU. J Nucl Med 29: 1957–1960
Daumas-Duport C (1992) Histological grading of gliomas. Curr Opin Neurol Neurosurg 5: 924–931
De La Paz RL, Patronas NJ, Brooks RA, Smith BH, Kornblith PL, Milam H, Di Chriro G (1983) Positron emission tomography study of suppression of gray matter glucose utilisation by brain tumors. AJNR 4: 826–829
De Witte O, Hildebrand J, Luxen A, Goldman S (1994a) Acute effect of BCNU on glucose metabolism in brain and glioblastoma. J Neurooncol 21: 4
De Witte O, Hildebrand J, Luxen A, Goldman S (1994b) Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 74: 2836–2842
Dean BI, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, Carey RE (1990) Gliomas: classification with MR imaging. Radiology 174: 411–415
Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jenning MT, Moots PL, Kessler RM (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195: 47–52
Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A (1989) (11C)L-methionine uptake in gliomas. Neurosurgery 25: 720–728
Derlon JM, Petit-Taboué MC, Dauphin F, Courtheoux P, Chapon F, Creissard P, Darcel F, Houtteville JP (1994) The in vivo metabolic assessment of benign brain gliomas with PET: different patterns and their implications. J Neurooncol 21: 1
Derlon JM, Petit-Taboue MC, Chapon F, Beaudouin V, Noel MH, Creveuil C, Courtheoux P, Houtteville JP (1997) The in vivo metabolic pattern of low grade brain gliomas; a PET study with 18F-fluorodeoxyglucose and 11C-L-methyl methionine. Neurosurgery 40: 276–288
Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J (1994) Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 35: 1162–1166
Di Chiro G, De La Paz RL, Sokolofl L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Glucose utilisation of cerebral gliomas measured by (18F) fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329
Di Chiro G, Books RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, Mansi L, Barker J (1984) Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15 [Suppl] S1: 38–S146
Di Chiro G (1986) Positron emission tomography using (18F) fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22: 360–371
Di Chiro G, Oldfield E, Wright DC, De Michele D, Patz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kufta CV (1987) Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. AJNR 8: 1083–1091
Di Chiro G (1994) Which PET radiopharmaceuticals for brain tumors? J Nucl Med 32: 1346–1347
Diksic M, Farrokhzad S, Yamamoto L, Feindel W (1982a) Synthesis of «no carrier added» HC-labeled BCNU. J Nucl Med 23: 895–898
Diksic M, Farrokhzad S, Yamamoto YL, Feinderl W (1982b) 11C and 13N-labelled BCNU and its in vivo pharmacokinetic study with PET. J Labelled Comput Radiopharm 19: 1394
Diksic M, Sako K, Feindel W, Kato A, Yamamoto YL, Farrohzad S, Thompson C (1984) Pharmacokinetics of positron-labeled l,3-bis(2-chloroethyl) nitrosourea in human brain tumors using positron emission tomography. Cancer Res 44: 3120–3124
Diksic M, Farrakhzad S, Yamamoto YL, Feindel W (1985) Synthesis of «no carrier-added» HC-labeled nitrosoureas. J Radioanal Nucl Chem 89: 45–54
Dooms GC, Hecht S, Brant-Zawadski M, Berthiaume Y, Norman D, Newton TH (1986) Brain radiation lesions: MR imaging. Radiology 158: 149–155
Doyle WK, Budinger TR, Valk PE, Levin VA, Gutin Ph (1987) Differentiation of cerebral radiation necrosis from tumor recurrence by (18F) FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11: 563–570
Ell PJ, Holman BL (1982) Computed emission tomography. Oxford University Press, Oxford
Ericson K, Lilja A, Bergstrom M, Collins VP, Eriksson L, Ehrin E, Von-Holst H, Lundqvist H, Langstrom BB, Mosskin M (1985) Positron emission tomography with (11C) methyl)-L-methionine, (11C)D-glucose and (68Ga) EDTA in supratentorial tumors. J Comput Assist Tomogr 9: 683–689
Ericson K, Blomqvist G, Bergstrom M, Eriksson L, Stone-Elander S (1987) Application of a kinetic model on the methionine accumulation in intra-cranial tumors studied with positron emission tomography. Acta Radiol 28: 505–509
Feiden W, Steude U, Bise K, Giindisch O (1991) Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14: 51–56
Ferrarese C, Appollonio I, Frigo M, Gaini SM, Piotri R, Frattola L (1989) Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors. Ann Neurol 26: 564–568
Ferrarese C, Pierapoli C, Linfante I, Bobo RH, Guthrie B, Kufta C, Duhaney MO, Melisi J, Fulham MJ (1994) Peripheral benzodiazepine receptors and glucose metabolism in human gliomas. J Neurooncol 22:15–22
Fishbein DS, Chrousos GA, Di Chiro G, Wayner RE, Patronas NJ, Larson SM (1987) Glucose utilization of visual cortex following extra-occipital interruptions of the visual pathways by tumor. A positron emission tomography study. J Clin Neuro Ophtalmol 7: 63–68
Forsting M, Albert FK, Kunze S, Adams HP, Zenner D, Sartor K (1993) Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR 14: 776–787
Frackowiak RSJ, Lenzi GL, Jones T, Heather JD (1982) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 4: 727–736
Fulling KH, Garcia DM (1985) Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic featrues. Cancer 55: 928–931
Ginos JZ, Cooper AJL, Dhawan V (1987) [13N] Cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med 28: 1844–1852
Glantz MJ, Hoffman JM, Coleman RE, Firedman AH, Hanson MW, Burger PC, Herndon J, Meisler WJ, Schold S Jr (1991) Identification of early recurrence of primary central nervous system tumors by 18F-fluorodeoxy-glucose positron emission tomography. Ann Neurol 29: 347–355
Graham JF, Cummins CJ, Smith BH, Kornblith PL (1985) Regulation of hexokinase in cultured gliomas. Neurosurgery 17: 537–542
Groothuis DR, Vick NA (1982) Brain tumors and the blood-brain barrier. Elsevier, Amsterdam, pp 232–235
Gwan Go K, Lammmertsma A, Paans AMJ, Vaalburg W, Woldring MG (1981) Extraction of water labeled with oxygen 15 during single-capillary transit. Influence of blood pressure, osmolarity, and blood-brain damage. Arch Neurol 38: 581–584
Hanson MW, Hoffman JM, Glantz MJ, Schold SC, Radtke RA, Friedman AH, Coleman RE (1990) FDG-PET in the early postoperative evaluation of patients with brain tumors. J Nucl Med (Abstract) 31: 799
Hanson MW, Glantz MJ, Hoffman JM (1991) FDG-PET in the selection of brain lesions for biopsy. J Comput Assist Tomogr 15: 796–801
Hatazawa J, Ishiwata K, Itoh M, Kameyama M, Kubota K, Ido T, Matsuzawa T, Yoshimoto T, Watanuki S, Seo S (1989) Quantitative evaluation of L-(methyl-C-l 1) methionine uptake in tumor using positron emission tomography. J Nucl Med 30: 1809–1813
Hawkins RA, Phelps ME, Huang SC, Wapenski JA, Grimm PD, Parker RG, Juillard G, Greenberg P (1984) A kinetic evaluation of blood-brain barrier permeability in human brain tumors with (68-Ga) edta and positron computed tomography. J Cereb Blood Flow Metab 4: 507–515
Herholz K, Pietrzyk U, Voges J, Schröeder R, Halber M, Treuer H, Sturm V, Heiss WD (1993) Correlation of glucose consumption and tumor cell density in astrocytomas. A sterotactic PET study. J Neurosurg 79: 853–858
Hiesiger E, Fowler JS, Wolf AP, Logan J, Brodie JD, McPherson D, McGregor RR, Christman DR, Wolkow ND, Flamm E (1987) Serial PET studies of human cerebral malignancy with (l-11C) putrescine and (1-11C)2-deoxy-D-glucose. J Nucl Med 28: 1251–1261
Hoffman RF, Werbe R (1976) High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci 73: 1523–1527
Holzer T, Herholz K, Jeske J, Heiss WD (1993) FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17: 681–687
Hoop B, Hnatowich DJ, Brownell GL, Jones T, McKusick KA, Ojemann RG, Parker JA, Subramanyam R, Taveras JM (1976) Techniques for positron scintigraphy of the brain. J Nucl Med 17: 473–479
Horton RW, Meldrum BS, Bachelard HS (1973) Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem 21: 507–520
Hossmann KA, Niebuhr I, Tamura M (1982) Local cerebral blood flow and glucose consumption of rats with experimental gliomas. J Cereb Blood Flow Metab 2: 25–32
Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE (1980) Non-invasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: E69–E82
Hubner KF, Purvis JT, Mahaley SM, Robertson Fr JT, Rogers S, Gibbs WD, King P, Partain CL (1982) Brain tumor imaging by positron emission computed tomography using 11C-labeled amino acids. J Comput Assist Tomogr 6: 544–550
Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, Punzo A, Del Vecchio L, Lenzi GL, Salvatore M, Conforti P (1987) Simplified, non-invasive PET measurement of blood-brain-barrier permeability. J Comput Assist Tomogr 11: 390–397
Ikezaki K, Black KL, Toga AW, Santori EM, Becker DP, Smith ML (1990a) Imaging peripheral benzodiazepine receptors in brain tumors in rats: in vitro binding characteristics. J Blood Flow Metabol 10: 580–587
Ikezaki K, Black KL, Santori EM, Becker DP, Payne BA, Toga AW (1990b) Three-dimensional comparison of peripheral benzodiazepine binding with histological findings in rat brain tumor. Neurosurgery 27: 78–82
Ishii K, Ogawa T, Hatazawa J, Kanno I, Inugami A, Fujita H, Shimose-gawa E, Murakami M, Okudera T, Uemura K (1993) High L-methyl-C 11 methionine uptake in brain abcess: a PET study. J Comput Assist Tomogr 17: 660–666
Ishiwata K, Ido T, Vaalburg W (1988a) Increased amounts of D-enantiomer dependent on alkaline concentration in the synthesis of L-methyl-11C-methionine. Appl Radiat Isot 39: 311–314
Ishiwata K, Vaalburg W, Elsinga PH, Paans AMJ, Woldring MG (1988b) Comparison of L-[l-11C]methionine and L-methyl-[11C]methionine for measuring in vivo protein syntheis with PET. J Nucl Med 29: 1419–1427
Ishiwata K, Vaalburg W, Elsinga PH, Paans AMJ, Woldring MG (1988c) Metabolic studies with L-1-14C Tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 29: 524–529
Ishiwata K, Hatazawa J, Kubota K, Kameyama M, Itoh M, Matzuzawa T, Takahashi T, Iwata R, Ido T (1989) Metabolic fate of L-(methyl-11C)-methionine in human plasma. Eur J Nucl Med 15: 665–669
Ishikawa M, Kikuchi H, Miyatake S, Oda Y, Yonekura Y, Nishizawa S (1993) Glucose consumption in recurrent gliomas. Neurosurgery 33: 28–33
Ito M, Lammentsma AA, Wise RJJ, Bernadi S, Frackowiak RJJ, Heather JD, McKenzie LG, Thomas DGT, Jones T (1982) Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumor using 15O and positron emission tomography: analytical technics and preliminary results. Neuroradiology 23: 63–74
Junck L, Olson JMM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, Mackeever PE, Wieland DM, Kilbourn JM, Starosta-Rubinstein S, Mancini WR, Kuhl DE, Greenberg HS, Young AB (1989) PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 26: 752–758
Kameyama M, Tsurumi Y, Shirane R, Katakura R, Suzuki J, Itoh M, Fukuda H, Matzuzawa T, Watanuki S, Ido T (1987) Multi-parametric analysis of brain tumor with PET. J Cereb Blood Flow Metabol 7 [Suppl 1]: S466
Kaschten B, Sadzot B, Stevenaert A (1994) Evaluation of brain tumor metabolism by PET J. Neurooncology 21: 1
Kawai K, Fujibayashi Y, Saji H (1991) A strategy for the study of cerebral amino acid transport using iodine 123 labeled amino acid radiopharmaceutical: 3-idio-alpha-methyl-L-tyrosine. J Nucl Med 32: 819–824
Kessler RM, Goble JC, Bird JH, Girton ME, Doppman JL, Rapoport SI, Barranger JA (1984) Measurement of blood-brain barrier permeability with positron emission tomography and 68Ga EDTA. J Cereb Blood Flow Metab 4: 324–328
Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, Hawkins RA, Becker DP (1990) Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 31: 965–969
Kim CK, Alavi JB, Alavi A, Reivich M (1991) New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxy-glucose. J Neurooncol 10: 85–91
Kirikae M, Diksic M, Yamamoto YL (1989) Quantitative measurements of regional glucose utilization and rate of valine incorporation into proteins by double-tracer autoradiography in the rat brain tumor model. J Cereb Blood Flow Metab 9: 87–95
Kubota K, Yamada K, Fukada H, Endo S, Ito M, Abe Y, Yamaguchi T, Fujimara T, Saro T, Ito K, Yoshioka S, Hatazawa J, Marsuzawa T, Iwata R, Ido T (1984) Tumor detection with carbon 11 labelled amino acids. Eur J Nucl Med 9: 136–140
Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, Ido T (1991) Tracer feasibility for monitoring tumor radiotherapy: A quadruple tracer study with fluorine-18 fluorodeoxyglucose or fiuorine-18 fluorodeoxyuridine, L-(methyl-14C) methionine, (6-3H) thymidine and gallium-67. J Nucl Med 32:2118–2123
Lammertsma AA, Jones T, Frackowiak RSJ, Lenzi GL (1981) A theoretical study of the steady-state model for measuring cerebral blood flow and oxygen utilization using oxygen-15. J Comput Assist Tomogr 5: 544–550
Lammertsma AA, Wise RJ, Cox TC, Thomas DG, Jones T (1985) Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumors and surrouding oedematous tissue. Br J Radiol 58: 725–734
Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE (1990) SPECT studies of brain tumors with L-3-1231-iodo-alpha-methyl tyrosine: comparison with PET, 124 IMT and first clinical results. J Nucl Med 31: 281–286
Langen KJ, Roosen N, Coenen H, Kuikka JT, Kuwert T, Herzog H, Stoocklin G, Feinendegen LE (1991) Brain and brain tumor uptake of L-3-1231-iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 32: 1225–1228
Laohaprasit V, Silbergeld DL, Ojemann GA, Eskridge JM, Winn HR (1990) Postoperative CT contrast enhancement following lobectomy for epilepsy. J Neurosurg 73: 392–395
Lasne MC, Barre L, Piarraud A, Lalaoui K, Giroux B, Derlon JM (1991) Synthesis of “no-carrier added” carbon-11 fotemustine. J labelled Comp radiopharma 30: 440–445
Leenders KL, Beaney RP, Brooks DJ, Lammertsma AA, Heather JD, McKenzie CG (1985) Dexamethasone treatment of brain tumor patients: Effects on regional blood flow, blood volume, and oxygen utilization. Neurology 35: 1610–1616
Levivier M, Goldman S, Bidaut L, Luxen A, Stanus E, Przedborski S, Baleriaux D, Hildebrand J, Brotchi J (1992) Positron tomography guided stereotactic brain biopsy. Neurosurgery 31: 792–797
Levivier M, Goldman S, Pirotte B, Brucher J, Baleriaux D, Luxen A, Hildebrand J, Brotchi J (1995) Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with 18F-Fluorodeoxyglucose. J Neurosurg 82: 445–452
Lilja A, Bergstrom K, Hartvig P, Spannare B, Halldin C, Lundqvist H, Langstrom B (1985) Dynamic study of supratentorial gliomas with L-methyl 11C-methionine and positron emission tomography. AJNR 6: 505–514
Magistretti PL (1983) Functional radionuclide imaging of the brain. Serono Symposia Publications 10d 5. Raven, New York
Martiat P, Ferrant L, Labard, Cogneau M, Bol A, Michel A, Michaux JL, Sokal G (1988) In vivo measurement of carbon-11 thymidine uptake in non Hodgkin’s lymphoma using positron emission tomography. J Nucl Med 19: 1633–1637
Martins AN, Johston JS, Henry JM, Stoffel TJ, Di Chiro J (1977) Delayed radiation necrosis of the brain. J Neurosurg 47: 336–345
Maublant JC, Gachon P, Moins N (1988) Hexakis (2-methoxy isobulisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med 29: 48–54
McKenzie CG, Lenzi GL, Jones T, Moss S (1978) Radioactive oxygen 15O studies in cerebral neoplasms. J R Soc Med 71: 417–425
Meyer GJ, Schober O, Hundeshagen H (1985) Uptake of 11 C-L-and D-methionine in brain tumors. Eur J Nucl Med 10: 373–376
Meyer CJ, Schober O, Gaab MR, Kietz H, Hundeshagen H (1989) Multi-parameter studies in brain tumors. In: Beckers C, Goffinet A, Bol A(eds) PET in clinical research and clinical diagnosis. Kluwer, Dordrecht, pp 229–248
Mineura K, Yasuda T, Kowada M, Shishido F, Ogawa T, Uemura K (1986) Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 8: 164–168
Mineura K, Sasajima T, Kowada M, Uesaka Y, Shishido F (1991) Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography. J Nucl Med 32: 726–728
Mosskin M, Holt V, Bergstrom M, Collins VP, Erikson L, Johnstrom P, Noren G (1987) Positron emission tomography with 11C-methionine and X-ray computed tomography of intracranial tumors compared with histopathologic observations in multiples biopsies. Acta Radiol Diag 28: 673–681
Moulinoux JP, Le Calve M, Quemener V, Quash G (1984a) In vitro studies of the entry of polyamines into normal red blood cells. Biochimie 66: 385–393
Moulinoux JP, Quemener V, Larzul JJ, Le Calve M, Roch M, Toujas L, Quash G (1984b) Red blood cell polyamines in mice bearing the Lewis lung carcinoma (3LL) and in patients with bronchopulmonary cancers. Int J Cancer 34: 277–281
Moulinoux JP, Quemener V, Le Calve M, Chatel M, Darcel F (1984c) Polyamines in human brain tumors. A correlative study between tumor, cerebrospinal fluid and red blood cell free polyamine levels. J Neurooncology 2: 153–158
Murakami M, Takahashi K, Kondo Y, Mizuzawa S, Nakamichi H, Sasaki H, Hagami E, Iida H, Kanno I, Miura S, Uemura K (1988) 2-18F-phenylaline and 3-18F-tyrosine. Synthesis and preliminary data of tracer kinetics. J Labelled Comp Radiopharmaceut 25: 773–782
Ogawa T, Uemura K, Kanno I, Shishido F, Inugami A, Yamaguchi T, Murakamin M, Hirata K, Kato T, Mineura K, Kowada M (1988a) Delayed radiation necrosis of brain evaluated by positron emission tomography. Tohoku J Exp 155: 247–260
Ogawa T, Uemura K, Shishido F, Yamaguchi T, Murakami M, Inugami A, Kanno I, Sasaki H, Kato T, Hirata K, Kowada M, Mineura K, Yasuda T (1988b) Changes of cerebral blood flow and oxygen and glucose metabolism following radiochemotherapy of gliomas: A PET study. J Comput Assist Tomogr 12: 290–297
Olson JM, McNeel W, Young AB, Mancini WR (1992) Localization of peripheral-type benzodiazepine binding site to mitochondria of human glioma cells. J Neurooncology 13: 35–42
O’Tuama LA, Travers ST, Larar JN, Packard AB, Kwan AJ, Barnes PD, Scott RM, Black P, Mcl, Madsen JR, Goumnerova LC, Sallan SE, Tarbell S, Tarbell NJ (1993) Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of chilhood brain tumors: a within-subject comparison. J Nucl Med 34: 1045–1051
Pantano P, Baron JC, Crouzel C, Collard P, Sirou P, Samson Y (1985) The 15O continuous-inhalation method: correction for intravascular signal using 15CO2. Eur J Nucl Med 10: 387–391
Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, Crouzel C, Hauw JJ, Syrota A (1991) PET study of carbon 11 PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med 32: 1608–1610
Patronas NJ, Di Chiro G, Brooks RA, De La Paz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O’Connor CM (1982) Work in progress: (18F) fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144: 885–889
Patronas NJ, Brooks RA, de la Paz RL, Smith BH, Kornblith PL, Di Chiro G (1983) Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR 4: 533–535
Patronas NJ, Di Chiro G, Kufta G, Bairamian D, Kornblith PL, Simon R, Larson SM (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 612–622
Pegg AE, McCann PP (1982) Polyamine memtabolism and function. Am J Physiol 243: C212–C221
Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic memasurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-de’oxy-D-glucose: validation of method. Ann Neurol 6: 371–378
Phelps ME, Barrio JR, Huang SC, Keen RE, Chugani H, Mazziotta JC (1986) Measurement of cerebral protein synthesis in man with positron computerized tomography: model, assumptions and preliminary results. In: Phelps ME, Mazziotta JC, Schelbert HR (eds) The metabolism of the human brain studied with positron emission tomography. Raven, New York, pp 215–232
Phelps ME, Mazziotta JC, Schelbert HR (1986) Positron emission tomography and autoradiography: principles and applications for the brain and heart. In: Phelps ME, Mazziotta JC, Schelbert HR (eds) The metabolism of the human brain studied with positron emission tomography. Raven-Press, New York
Pirotte B, Goldman S, Brucher JM, Zomosa G, Balériaux D, Brotchi J, Levivier M (1994) PET in stereotactic conditions increases the diagnostic yield of brain therapy. Stereotact Funct Neurosurg 63: 144–149
Plate KH, Breier G, Weich HA, Risau W (1992) Vacular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas. Nature 359: 845–848
Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL (1996) Accurate noninvasive diagnosis of human brain by using proton magnetic resonance spectroscopy. Nature Med 2: 323–325
Quemener V, Darcel F, Chatel M, Moulinoux JP (1986) Can polyamines act as positron emitter in cerebral oncology? Preliminary results obtained in nude mice bearing human glioblastoma xenografts. In: Chatel M, Darcel F, Pecker J (eds) Brain oncology. Martinus Nijhoff, Dordrecht, pp 201–204
Reivich M, Alavi A (eds) (1985) Positron emission tomography. Liss, New York
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH (1985) Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for 18F-fluorodeoxyglucose and 11C-deoxyglucose. J Cereb Blood Flow Metab 5: 179–192
Rhodes CG, Wise RJS, Gibbs M, Frackoviak RSJ, Hatazawa J, Palmer AJ, Thomas DJT, Jones T (1983) In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 14: 614–626
Richfield EK, Ciliax BJ, Starosta-Rubinstein SR, Keever PE, Penney JB, Young AB (1988) Comparison of (14C)-deoxyglucose metabolism and peripheral benzodiazepine receptor binding in rat C6 glioma. Neurology 38: 1255–1262
Roelcke U (1994) PET: Brain tumor biochemistry. J Neurooncology 22: 275–279
Rogers S, Robertson JT (1981) A method of studying metabolic variation between individual tumors. Nutr Cancer 2: 148–149
Rottenberg DA, Ginos JZ, Kearfott KJ, Junck L, Bigner DD (1984) In vivo measurement of regional brain tissue pH using positron emission tomography. Ann-Neurol 15 [Suppl]: S98–S102
Rottenberg DA, Ginos JZ, Kearfott KJ, Dhawan V, Jarden JO (1985) In vivo measurement of brain tumor pH using (11C) DMO and positron emission tomography. Ann Neurol 17: 70–79
Rottinger EM, Mendouca BA (1980) Modification of pH induced cellular inactivation by irradiation-glial cells. Int J Radiat Oncol Biol Phys 6: 1659–1662
Rozental JM, Levine RL, Nickles RJ, Dobkin JA (1989) Glucose uptake by gliomas after treatment. Arch Neurol 46: 1302–1307
Rozental JM, Cohen JD, Mehta MP, Levine RL, Hanson JM, Nickles RJ (1993) Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme. J Neurooncology 15: 57–66
Rutten EHJ, Doesburg WH, Slooff JL (1992) Histologic factors in the grading and prognosis of astrocytoma grade I–IV. J Neurooncology 13: 223–230
Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K (1990) Ringlike uptake of 18F-FDG in brain abcess: a PET study. J Comput Assist Tomogr 14: 486–487
Sato K, Kameyama M, Ishiwata K, Katakura R, Yoshimoto Y (1992) Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers. J Neurooncology 14: 81–89
Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC, Coleman RE (1993) Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17: 509–516
Shields AF, Quackenbush RC, Coonrod DV (1986) Development of C-11 thymidine as a PET imaging agent: biochemistry of its synthesis, degradation, and reutilization (abstract). J Nucl Med 27: 1033
Shields A, Lim K, Grierson J, Link J, Krohn K (1990) Utilization of labeled thymidine in DNA synthesis: studies for PET. J Nucl Med 31: 337–342
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845
Sokoloff L, Reivich M, Kennedy M, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The 14C-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–913
Sokoloff L (ed) (1985) Brain imaging and brain function. Raven, New York
Tjuvajev J, Abrams D, Ginos J, Desai R, Finn R, Blasberg R (1993a) Iodo-deoxyruidine (IUdR) imaging for tumor proliferation: correlation with-kinetic parameters of local tumor cell proliferation. Neurology 43: A399
Tjuvajev J, Muraki A, Ginos J, Berk J, Kourcher J, Ballon D, Beattie B, Finn R, Blasberg R (1993b) Iododeoxyuridine uptake and retention as a measure of tumor growth. J Nucl Med 34: 1152–1162
Tsurumi Y, Kameyama M, Ishiwata K, Katakura R, Monma M, Ido T, Suzuki J (1990) 18F-fluoro-2 deoxyuridine as a tracer of nucleic acid metabolism in brain tumors. J Neurosurg 72: 110–113
Tyler JL, Yamamoto YL, Diksic M, Theron J, Villemure JG, Worsinghton C, Evans AC, Feindel W (1986) Pharmacokinetics of superselective intra-arterial and intravenous (11 C) BCNU evaluated by PET. J Nucl Med 27: 775–780
Tyler JL, Diksic M, Villemure JG, Evans AC, Meyer E, Yamamoto YL, Feindel W (1987) Metabolic and hemodynamic evaluation of glicomas using positron emission tomography. J Nucl Med 28: 1123–1133
Tyler JL, Strother S, Zatorre RJ, Alivisatos B, Worsley KJ, Diksic M, Yamamoto YL (1988) Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med 29: 631–642
Vander Borght T, Pauwels S, Lambotte L, Labar S, De Maeght S, Stroobandt G, Laterre C (1994) Brain tumor imaging with PET and 2-(carbon-11) thymidine. J Nucl Med 35: 974–982
Viader F, Derlon JM, Petit-Tavoué MC, Shishido F, Hubert P, Houtteville JP, Courtheoux P, Chapon F (1993) Recurrent oligodendroglioma diagnosed with 11C-L-methionine and PET: a case report. Eur Neurol 33: 248–251
Volkow N, Goldman SS, Flamm ES, Cravioto H, Wolf AP, Brodie JD (1983) Labeled putrescine as a probe in brain tumors. Science 221: 673–675
Wackers F, Berman D, Maddahi J (1989) Techmcium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30: 301–311
Warburg O (1956) On the origin of cancer cells. Science 123: 309–314
Warnick RE, Pietronigro DD, Duncan D, McBride Q, Flamm ES (1989) In vivo metabolism of radiolabeled putrescine in gliomas. Implications for positron emission tomography of brain tumors. Neurosurgery 23: 464–469
Weisberg LA (1980) Cerebral computed tomography in diagnosis of supra-tentorial astrocytoma. Computerized tomography, vd 4. Pergamon, Elunsford, NY, pp 87–105
Wike-Hooley JL, Van den Berg AP, Van der Zee J, Reinhold HS (1985) Human tumour pH and its variation. Eur J Cancer Clin Oncol 21: 785–791
Wilson MJ, Poirier LA (1987) An increased requirement for methionine by transformed rat liver epithelial cells in vitro. Exp Cell Res 111: 397–400
Yamaguchi T, Ssaski H, Ogawa T, Mineura K, Uemura K, Kanno I, Shishido F, Murakami M, Inugami A, Higano S (1986) Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors. Acta Radiol [Suppl] 369: 415–418
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Wien
About this chapter
Cite this chapter
Derlon, J.M. (1998). The in vivo Metabolic Investigation of Brain Gliomas with Positron Emission Tomography. In: Cohadon, F., et al. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery, vol 24. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6504-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6504-1_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7339-8
Online ISBN: 978-3-7091-6504-1
eBook Packages: Springer Book Archive